Dermazone Solutions, Inc

Form 483 issued December 6, 2022 · Saint Petersburg, Florida

Inspection
Nov 21 – Dec 6, 2022
Investigator
Kayla V. Sprague
Observations
3
Pages
4
FEI number
1000113908

In short: On December 6, 2022, FDA issued a Form 483 with 3 observations to Dermazone Solutions, Inc in Saint Petersburg, Florida (FEI 1000113908) after an inspection that ran Nov 21 – Dec 6, 2022. The investigator was Kayla V. Sprague. Most observations concern quality system and laboratory controls; the most-cited regulation is 21 CFR 211.192 (production record review).

At a glance

2 of 3 observations on this 483 concern quality system.

Quality system2
Laboratory controls1

Most cited: 21 CFR 211.192 (2×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    The quality control unit lacks authority to review production records to assure that no errors have…

  2. 02

    Verification of the suitability of the testing methods is deficient in that they are not performed…

  3. 03

    Written records of investigations into unexplained discrepancies and the failure of a batch or any of…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Dermazone Solutions, Inc?

FDA listed 3 observations on this Form 483, mostly about quality system and laboratory controls. The most-cited regulation is 21 CFR 211.192 (production record review). The opening words of each observation are shown on this page.

Who inspected Dermazone Solutions, Inc?

Kayla V. Sprague is named on this Form 483, for the inspection of Nov 21 – Dec 6, 2022. Each investigator has a profile showing what they cite most.

When was Dermazone Solutions, Inc inspected by FDA?

The inspection ran Nov 21 – Dec 6, 2022, and the Form 483 is dated December 6, 2022.

How do I get the full Form 483 for Dermazone Solutions, Inc?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free